Contact
searchSearch
HMP Global

Hidradenitis Suppurativa Topic Center

Featured

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Jessica Garlewicz
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
Lisa Kuhns, PhD, MD
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Lisa Kuhns, PhD, MD
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
Lisa Kuhns, PhD, MD
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Lisa Kuhns, PhD, MD
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Lisa Kuhns, PhD, MD
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Lisa Kuhns, PhD, MD
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
News
Increased Epigenetic Age May Be a Biomarker of Disease Burden in Hidradenitis Suppurativa
11/09/2022
Lisa Kuhns, PhD, MD
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot...
11/09/2022
The Dermatologist

Q&As

Dr Amit Garg: Comorbidity Screening in HS
Q&As
Dr Amit Garg: Comorbidity Screening in HS
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
Q&As
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
04/24/2021
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD...
04/24/2021
The Dermatologist
The Who and When of Intralesional Injections for HS Treatment
Q&As
The Who and When of Intralesional Injections for HS Treatment
03/26/2021
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met...
03/26/2021
The Dermatologist
Part 1 roundtable
Q&As
Part 1: Understanding the Emotional and Physical Toll of Alopecia Areata
08/04/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful...
08/04/2025
The Dermatologist
Brandon Adler, MD
Q&As
Insights Into Photoprotection Updates
02/08/2024
Jessica Garlewicz
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the...
02/08/2024
The Dermatologist
Glynis Ablon
Q&As
Enhancing Appearance Procedures
02/04/2024
Riya Gandhi, MA
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon...
02/04/2024
The Dermatologist
Jonathan Silverberg, MD, PhD, MPH
Q&As
Revolutionizing Atopic Dermatitis: Virtual Sessions on Optimizing Patient Care
12/13/2023
Jessica Garlewicz
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed...
12/13/2023
The Dermatologist
Elliott Campbell
Q&As
Gender Disparities and Advances in Cutaneous Melanoma
11/01/2023
Elliott Campbell, MD, FAAD
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men.
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men.
In this interview, Dr Elliott...
11/01/2023
The Dermatologist
Ilka A. Netravali, MD, PhD, FAAD
Q&As
Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis
10/30/2023
Ilka Arun Netravali, MD, PhD, FAAD
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared...
10/30/2023
The Dermatologist
Jeremy Etzkorn-2019
Q&As
Nasal Function and Appearance Post Flap Repair: NAFEQ Study
09/26/2023
Jeremy Etzkorn, MD; Nicholas J. Golda, MD
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn...
09/26/2023
The Dermatologist
Steven Feldman
Q&As
Advancing Psoriasis Patient Care
09/25/2023
Steven R. Feldman, MD, PhD
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The...
09/25/2023
The Dermatologist
Derek Chu, MD, PhD, FRCPC
Q&As
Systemic and Topical Treatments For Atopic Dermatitis
09/20/2023
Jessica Garlewicz
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview with...
09/20/2023
The Dermatologist
Emily Ruiz, MD, MPH
Q&As
Nonsurgical Approaches for Skin Cancer
09/12/2023
Emily Ruiz, MD, MPH
In this interview, Dr Emily Ruiz offers a glimpse into her upcoming session, “Nonsurgical Treatments for Skin Cancer,” at Dermatology Week Fall 2023.
In this interview, Dr Emily Ruiz offers a glimpse into her upcoming session, “Nonsurgical Treatments for Skin Cancer,” at Dermatology Week Fall 2023.
In this interview, Dr Emily Ruiz...
09/12/2023
The Dermatologist

Multimedia

Dr Sherry Yang
Videos
Inflammation's Role in the Disease Progression of HS
11/17/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the...
11/17/2021
The Dermatologist
Dr Sherry Yang
Videos
Demographics & Characteristics Associated With HS Diagnoses
11/12/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient...
11/12/2021
The Dermatologist
Dr Sherry Yang
Videos
How to Approach HS Treatment
11/05/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how...
11/05/2021
The Dermatologist
Videos
Clinical Implications of HS and Hepatitis B/C
06/10/2021
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical...
06/10/2021
The Dermatologist
Videos
Genetic Components and Hepatitis Risks in HS
06/10/2021
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr...
06/10/2021
The Dermatologist
Podcasts
Updates in HS: Dr Rosenblum on Pathophysiology
12/15/2020
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael...
12/15/2020
The Dermatologist
Podcasts
Dr Iltefat Hamzavi on Managing Hidradenitis Suppurativa
09/16/2020
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat...
09/16/2020
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
part 2
Videos
Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata
09/08/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of...
09/08/2025
The Dermatologist
Dr Omid Hamid
Videos
Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results
08/15/2025
Omid Hamid, MD
08/15/2025
The Dermatologist
Glynis Ablon, MD, and Neil Sadick, MD presenters
Videos
Expert Perspectives: Hair Loss Management in Dermatology Practice
08/08/2025
Neil S. Sadick, MD, FAAD; Glynis Ablon
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the...
08/08/2025
The Dermatologist
George Murakawa
Videos
Infusion Therapy for Non-Melanoma Skin Cancer: A Dermatologist’s Guide
07/31/2025
George J. Murakawa, MD, PhD
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology...
07/31/2025
The Dermatologist
Expert Roundtable
Videos
Part 1: The Emotional and Physical Toll of Severe Alopecia Areata
07/21/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this expert roundtable, Drs Brittany Craiglow, Brett King, and Maryanne Senna discuss the emotional and psychosocial weight patients carry—and how clinicians can meet their needs with empathy and understanding.
In this expert roundtable, Drs Brittany Craiglow, Brett King, and Maryanne Senna discuss the emotional and psychosocial weight patients carry—and how clinicians can meet their needs with empathy and understanding.
In this expert roundtable, Drs...
07/21/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Elderderm: Episode 5, Deep and Dutiful Dialogues About Down Below
07/10/2025
Adam Friedman, MD
Dr Emily Murphy joins ElderDerm for a focused discussion on vulvar dermatoses in older adults.
Dr Emily Murphy joins ElderDerm for a focused discussion on vulvar dermatoses in older adults.
Dr Emily Murphy joins ElderDerm...
07/10/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
nahid vidal
Videos
Mohs Surgery for Anogenital and Perineal Tumors: Expert Insights
07/08/2025
Nahid Y. Vidal, MD, FAAD
In this video, Dr Nahid Vidal delves into the complexities of managing anogenital tumors with Mohs surgery.
In this video, Dr Nahid Vidal delves into the complexities of managing anogenital tumors with Mohs surgery.
In this video, Dr Nahid Vidal...
07/08/2025
The Dermatologist
Dr Maryanne Senna
Podcasts
The Reality of Alopecia Areata: Dispelling Myths and Raising Awareness, Part 2
06/20/2025
Maryanne Makredes Senna, MD
In this follow-up episode, Dr Senna tackles seven of the most common myths surrounding alopecia areata (AA)—from the belief that stress is the sole cause to misconceptions about hygiene, diet, and permanence. She also clarifies treatment...
In this follow-up episode, Dr Senna tackles seven of the most common myths surrounding alopecia areata (AA)—from the belief that stress is the sole cause to misconceptions about hygiene, diet, and permanence. She also clarifies treatment...
In this follow-up episode, Dr...
06/20/2025
The Dermatologist

Quizzes

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Jessica Garlewicz
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Jessica Garlewicz
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist

News

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Jessica Garlewicz
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
Lisa Kuhns, PhD, MD
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Lisa Kuhns, PhD, MD
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
Lisa Kuhns, PhD, MD
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Lisa Kuhns, PhD, MD
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Lisa Kuhns, PhD, MD
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Lisa Kuhns, PhD, MD
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist

Popular Articles

Feature Story
Proposing an Algorithm to Treat Dystrophic Toenails
10/17/2023
Tracey C. Vlahovic, DPM, FFPM, RCPS(Glasg)
Familiarity with the key points and questions outlined in the proposed algorithm is the first step in optimizing outcomes for these patients.
Familiarity with the key points and questions outlined in the proposed algorithm is the first step in optimizing outcomes for these patients.
Familiarity with the key points...
10/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
psoriatic arthritis
News
Development of a New Index for Psoriatic Arthritis Activity
01/03/2024
Jessica Garlewicz
Researchers aimed to develop a comprehensive index for assessing psoriatic arthritis activity, integrating various clinical parameters.
Researchers aimed to develop a comprehensive index for assessing psoriatic arthritis activity, integrating various clinical parameters.
Researchers aimed to develop a...
01/03/2024
The Dermatologist
psoriatic arthritis
News
Assessing Areal Bone Mineral Density in Psoriatic Arthritis and Psoriasis
02/15/2024
Jessica Garlewicz
Researchers aimed to assess bone mineral density and bone quality in patients with psoriasis alone or with psoriatic arthritis compared to matched control subjects.
Researchers aimed to assess bone mineral density and bone quality in patients with psoriasis alone or with psoriatic arthritis compared to matched control subjects.
Researchers aimed to assess bone...
02/15/2024
The Dermatologist
Dr David Carr
Videos
Advancing a Mohs Surgery Leadership Program
04/03/2024
David R. Carr, MD, MPH, FACMS
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr...
04/03/2024
The Dermatologist

Subscribe

The Dermatologist Newsletter
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive

Latest Quizzes and Trivia

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Jessica Garlewicz
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Jessica Garlewicz
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use